Potentially curable metastatic colorectal cancer. 2008

Matthew Katz, and Jean-Nicolas Vauthey
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA.

Although patients with metastatic colorectal cancer have historically had a uniformly dismal prognosis, recent advances in chemotherapeutics and surgical techniques allow many patients to be treated with the potential for long-term survival and cure. Patients with potentially curable disease are those in whom multidisciplinary strategies including surgery can result in safe resection of all metastatic disease with negative margins. Although favorable outcomes using such strategies can increasingly be predicted, the presence of poor prognostic factors does not necessarily represent a contraindication to the use of a potentially curative strategy as long as a margin-negative resection can ultimately be obtained. Further analysis of the innovative strategies and techniques described in this article are needed to maximize cure rates in patients with this disease.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

Matthew Katz, and Jean-Nicolas Vauthey
June 2011, Current oncology reports,
Matthew Katz, and Jean-Nicolas Vauthey
March 2012, Oncology (Williston Park, N.Y.),
Matthew Katz, and Jean-Nicolas Vauthey
May 2009, Current oncology reports,
Matthew Katz, and Jean-Nicolas Vauthey
September 2017, Cureus,
Matthew Katz, and Jean-Nicolas Vauthey
February 2024, Surgical endoscopy,
Matthew Katz, and Jean-Nicolas Vauthey
April 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Matthew Katz, and Jean-Nicolas Vauthey
February 2012, American journal of clinical oncology,
Matthew Katz, and Jean-Nicolas Vauthey
December 1982, Cancer,
Copied contents to your clipboard!